Effects of lobeglitazone on insulin resistance and hepatic steatosis in high-fat diet-fed mice

Lobeglitazone (Lobe) is a novel thiazolidinedione antidiabetic drug that reduces insulin resistance by activating peroxisome proliferator-activated receptor-gamma (PPARγ). However, the exact mechanisms of antidiabetic effects of Lobe have not been established in an animal model. The aim of this stud...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:PLoS One
Egile Nagusiak: Choi, Bong-Hoi, Jin, Zhen, Yi, Chin-ok, Oh, Juhong, Jeong, Eun Ae, Lee, Jong Youl, Park, Kyung-ah, Kim, Kyung Eun, Lee, Jung Eun, Kim, Hyun-Jin, Hahm, Jong Ryeal, Roh, Gu Seob
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Public Library of Science 2018
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6034891/
https://ncbi.nlm.nih.gov/pubmed/29979770
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0200336
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak